Which of the following is considered a first-line treatment for Generalized Anxiety Disorder?

Selective serotonin reuptake inhibitors (SSRIs) are recognized as a first-line treatment for Generalized Anxiety Disorder (GAD) due to their efficacy and favorable side effect profile. SSRIs work by increasing the levels of serotonin in the brain, which is thought to have a positive impact on mood and anxiety regulation. This class of medication has been extensively studied and proven effective for treating anxiety disorders, including GAD.

In contrast, antipsychotics are primarily used to manage conditions such as schizophrenia and bipolar disorder, making them less suitable for GAD. Benzodiazepines can provide rapid relief of anxiety symptoms but are generally not recommended for long-term management due to the potential for dependence and withdrawal issues. Stimulants, on the other hand, are mainly indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) and can actually exacerbate anxiety symptoms in some individuals. Therefore, SSRIs stand out as the preferred initial treatment option for managing Generalized Anxiety Disorder effectively.